Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) Short Interest Down 11.2% in June

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) was the target of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 11,470,000 shares, a decrease of 11.2% from the May 31st total of 12,910,000 shares. Based on an average trading volume of 2,600,000 shares, the days-to-cover ratio is presently 4.4 days. Approximately 4.3% of the shares of the stock are sold short.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “neutral” rating and issued a $0.35 price objective on shares of Asensus Surgical in a report on Thursday, May 16th.

Asensus Surgical Stock Down 0.4 %

NYSEAMERICAN:ASXC traded down $0.00 during trading hours on Wednesday, hitting $0.33. The company had a trading volume of 71,608 shares, compared to its average volume of 1,900,730. Asensus Surgical has a 1 year low of $0.20 and a 1 year high of $0.65. The stock has a market cap of $89.95 million, a P/E ratio of -1.07 and a beta of 1.36.

Asensus Surgical (NYSEAMERICAN:ASXC) last announced its quarterly earnings data on Tuesday, May 14th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.02). Asensus Surgical had a negative net margin of 902.25% and a negative return on equity of 184.10%. The firm had revenue of $1.12 million during the quarter, compared to analysts’ expectations of $1.10 million. On average, equities analysts anticipate that Asensus Surgical will post -0.24 earnings per share for the current year.

Institutional Investors Weigh In On Asensus Surgical

An institutional investor recently raised its position in Asensus Surgical stock. Virtu Financial LLC boosted its stake in Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) by 834.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 249,019 shares of the company’s stock after buying an additional 222,368 shares during the period. Virtu Financial LLC owned approximately 0.09% of Asensus Surgical worth $57,000 at the end of the most recent quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

About Asensus Surgical

Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients.